These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 18829784)

  • 1. An intervention to decrease narcotic-related adverse drug events in children's hospitals.
    Sharek PJ; McClead RE; Taketomo C; Luria JW; Takata GS; Walti B; Tanski M; Nelson C; Logsdon TR; Thurm C; Federico F
    Pediatrics; 2008 Oct; 122(4):e861-6. PubMed ID: 18829784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.
    Takata GS; Mason W; Taketomo C; Logsdon T; Sharek PJ
    Pediatrics; 2008 Apr; 121(4):e927-35. PubMed ID: 18381521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of the Agency for Healthcare Research and Quality Patient Safety Indicators for children's hospitals.
    Sedman A; Harris JM; Schulz K; Schwalenstocker E; Remus D; Scanlon M; Bahl V
    Pediatrics; 2005 Jan; 115(1):135-45. PubMed ID: 15579669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment.
    Ferranti J; Horvath MM; Cozart H; Whitehurst J; Eckstrand J
    Pediatrics; 2008 May; 121(5):e1201-7. PubMed ID: 18450863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing controlled substance prescribing errors in a pediatric teaching hospital: an analysis of the safety of analgesic prescription practice in the transition from the hospital to home.
    Lee BH; Lehmann CU; Jackson EV; Kost-Byerly S; Rothman S; Kozlowski L; Miller MR; Pronovost PJ; Yaster M
    J Pain; 2009 Feb; 10(2):160-6. PubMed ID: 19010736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication safety program reduces adverse drug events in a community hospital.
    Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
    Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of adverse events in pediatric surgery using criteria validated from the adult population: justifying the need for pediatric-focused outcome measures.
    Rice-Townsend S; Hall M; Jenkins KJ; Roberson DW; Rangel SJ
    J Pediatr Surg; 2010 Jun; 45(6):1126-36. PubMed ID: 20620307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication errors: an analysis comparing PHICO's closed claims data and PHICO's Event Reporting Trending System (PERTS).
    Benjamin DM; Pendrak RF
    J Clin Pharmacol; 2003 Jul; 43(7):754-9. PubMed ID: 12856390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reactions among children over a 10-year period.
    Le J; Nguyen T; Law AV; Hodding J
    Pediatrics; 2006 Aug; 118(2):555-62. PubMed ID: 16882807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustaining and spreading the reduction of adverse drug events in a multicenter collaborative.
    Tham E; Calmes HM; Poppy A; Eliades AB; Schlafly SM; Namtu KC; Smith DM; Vitaska MC; McConnell C; Potts AL; Jastrzembski J; Logsdon TR; Hall M; Takata GS
    Pediatrics; 2011 Aug; 128(2):e438-45. PubMed ID: 21727100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective interventions and implementation strategies to reduce adverse drug events in the Veterans Affairs (VA) system.
    Mills PD; Neily J; Kinney LM; Bagian J; Weeks WB
    Qual Saf Health Care; 2008 Feb; 17(1):37-46. PubMed ID: 18245218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the agency for healthcare research and quality pediatric quality indicators.
    Scanlon MC; Harris JM; Levy F; Sedman A
    Pediatrics; 2008 Jun; 121(6):e1723-31. PubMed ID: 18474532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multidisciplinary approach to adverse drug events in pediatric trauma patients in an adult trauma center.
    Kalina M; Tinkoff G; Gleason W; Veneri P; Fulda G
    Pediatr Emerg Care; 2009 Jul; 25(7):444-6. PubMed ID: 19564808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk reduction for adverse drug events through sequential implementation of patient safety initiatives in a children's hospital.
    Leonard MS; Cimino M; Shaha S; McDougal S; Pilliod J; Brodsky L
    Pediatrics; 2006 Oct; 118(4):e1124-9. PubMed ID: 17015504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systems approach to preventing adverse drug events.
    Anderson JG
    Stud Health Technol Inform; 2003; 92():95-102. PubMed ID: 15455844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring amiodarone's toxicities: recommendations, evidence, and clinical practice.
    Stelfox HT; Ahmed SB; Fiskio J; Bates DW
    Clin Pharmacol Ther; 2004 Jan; 75(1):110-22. PubMed ID: 14749697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between computerized physician order entry and pediatric adverse drug events: a nested matched case-control study.
    Yu F; Salas M; Kim YI; Menachemi N
    Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):751-5. PubMed ID: 19479715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction--databases and the assessment of complications associated with the treatment of patients with congenital cardiac disease.
    Jacobs JP
    Cardiol Young; 2008 Dec; 18 Suppl 2():1-37. PubMed ID: 19063774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving self-reporting of adverse drug events in a West Virginia hospital.
    Schade CP; Hannah K; Ruddick P; Starling C; Brehm J
    Am J Med Qual; 2006; 21(5):335-41. PubMed ID: 16973950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical safety paediatric patients].
    Requena J; Miralles JJ; Mollar J; Aranaz JM
    Rev Calid Asist; 2011; 26(6):353-8. PubMed ID: 22033382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.